Armata Pharmaceuticals Inc (ARMP)
2.25
+0.15
(+7.14%)
USD |
NYAM |
Nov 22, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Cash from Operations (Quarterly): -8.863M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.863M |
| June 30, 2024 | -10.18M |
| March 31, 2024 | -10.58M |
| December 31, 2023 | -8.106M |
| September 30, 2023 | -9.687M |
| June 30, 2023 | -12.06M |
| March 31, 2023 | -17.57M |
| December 31, 2022 | -10.48M |
| September 30, 2022 | -10.33M |
| June 30, 2022 | -8.148M |
| March 31, 2022 | -3.515M |
| December 31, 2021 | -8.598M |
| September 30, 2021 | -4.964M |
| June 30, 2021 | -4.538M |
| March 31, 2021 | -5.475M |
| December 31, 2020 | -6.302M |
| September 30, 2020 | -3.88M |
| June 30, 2020 | -3.856M |
| March 31, 2020 | -4.232M |
| December 31, 2019 | -2.729M |
| September 30, 2019 | -4.567M |
| June 30, 2019 | -5.827M |
| March 31, 2019 | -2.459M |
| December 31, 2018 | -1.95M |
| Date | Value |
|---|---|
| September 30, 2018 | -1.723M |
| June 30, 2018 | -2.173M |
| March 31, 2018 | -3.536M |
| December 31, 2017 | -2.369M |
| September 30, 2017 | -0.593M |
| June 30, 2017 | -2.931M |
| March 31, 2017 | -3.299M |
| December 31, 2016 | -1.498M |
| September 30, 2016 | -3.131M |
| June 30, 2016 | -2.892M |
| March 31, 2016 | -3.085M |
| December 31, 2015 | -2.317M |
| September 30, 2015 | -2.497M |
| June 30, 2015 | -2.662M |
| March 31, 2015 | -2.305M |
| December 31, 2014 | -3.20M |
| September 30, 2014 | -2.627M |
| June 30, 2014 | -3.054M |
| March 31, 2014 | -3.691M |
| December 31, 2013 | -1.412M |
| September 30, 2013 | -2.494M |
| June 30, 2013 | -1.267M |
| March 31, 2013 | -1.119M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.57M
Minimum
Mar 2023
-2.729M
Maximum
Dec 2019
-7.705M
Average
-8.127M
Median
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -3.11M |
| Perspective Therapeutics Inc | 3.366M |
| Protalix BioTherapeutics Inc | 4.105M |
| Electromed Inc | 2.309M |
| Xtant Medical Holdings Inc | -1.718M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.34M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow | -42.09M |
| Free Cash Flow Per Share (Quarterly) | -0.2544 |
| Free Cash Flow Yield | -44.90% |